NCT06745297View on ClinicalTrials.gov

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

PHASE1RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

August 25, 2026

Study Completion Date

August 25, 2026

Conditions
Healthy
Interventions
DRUG

BI 3776528

BI 3776528

DRUG

Placebo matching BI 3776528

Placebo matching BI 3776528

DRUG

short-acting benzodiazepine

short-acting benzodiazepine

Trial Locations (1)

10117

RECRUITING

Charité Research Organisation GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06745297 - A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated | Biotech Hunter | Biotech Hunter